Ru-Ting Huang Selected Research

Ru-Ting Huang Research Topics

3	Atherosclerosis 01/2022 - 12/2014
1	Vascular Remodeling 12/2021
1	Pathologic Constriction (Stenosis) 12/2021
1	Idiopathic Pulmonary Fibrosis 01/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Hypoxia (Hypoxemia) 01/2017
1	Acute Lung Injury 01/2017
1	Lung Injury 01/2017
1	Virus Diseases (Viral Diseases) 01/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2015

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
2	ThioredoxinsIBA 01/2022 - 01/2020
2	Apolipoproteins E (ApoE)IBA 01/2022 - 12/2021
2	MicellesIBA 12/2021 - 12/2014
2	PolyelectrolytesIBA 12/2021 - 12/2014
2	MicroRNAs (MicroRNA)IBA 01/2016 - 12/2014
1	Protein Disulfide-IsomerasesIBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	NAD (NADH)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Phosphatidate PhosphataseIBA 07/2015
1	lipid phosphate phosphataseIBA 07/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2015
1	lysophosphatidic acidIBA 07/2015
1	Glutamic Acid (Glutamate)FDA Link 12/2014
1	Peptides (Polypeptides)IBA 12/2014
1	Lysine (L-Lysine)FDA Link 12/2014
1	Arginine (L-Arginine)FDA Link 12/2014
1	Alanine (L-Alanine)FDA Link 12/2014

2	Therapeutics 01/2022 - 12/2021